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Abstract
Introduction: Pituitary stalk interruption syndrome is a rare congenital abnormality of the pituitary that is responsible
for anterior pituitary deficiency. It is characterized by a classic triad of interrupted pituitary stalk, absent or ectopic
posterior pituitary, and anterior pituitary hypoplasia or aplasia. Clinical presentation varies according to age. In
adults it presents as short stature and anterior pituitary deficiency. Without early diagnosis and treatment, mortality and
morbidity in these patients is high. Early diagnosis and treatment of this rare disease can prevent permanent short
statue of the patient. We report the first case of pituitary stalk interruption syndrome from Pakistan.
Case presentation: A 17-year-old Pakistani young man presented with short stature and underdeveloped secondary
sexual characters. His siblings and parents were healthy, with normal height. An examination showed his blood pressure
was 90/60mmHg, and his height, weight, and body mass index were 142cm, 34.5kg, and 17.10kg/m2, respectively. He
had no hair growth on his face, axilla, or pubis. His testes were between 1 and 2mL in size, with a 4cm-at-stretch
micropenis. His lab investigations showed that his thyroid stimulating hormone (TSH) was 8.58uIU/mL (0.4 to 4.2),
his free thyroid hormone level FT4 was 0.46ng/dL (0.89 to 1.76), his prolactin was 21.1ng/mL (3.0 to 14.7), and his
baseline cortisol was 0.30ug/dL (4.3 to 22.4). His cortisol level after 60 minutes of cosyntropin injection was 3.5ug/dL
(4.3 to 22.4), his insulin like growth factor IGF-1 was 31.56ng/mL (247.3 to 481.7), his testosterone level was under
2.5ng/dL (2 to 800), his follicle stimulating hormone FSH was 0.41uIU/mL (0.0 to 10.0), and his leutinizing hormone LH
was under 0.1uIU/mL (1.2 to 7.8). His bone age was 10 years according to the Greulich and Pyle method, as shown by
X-rays. The results from his pituitary magnetic resonance imaging scan were consistent with pituitary stalk interruption
syndrome.
Conclusions: We describe a young man who presented with short stature and was found to have pituitary stalk
interruption syndrome. Despite the fact that this is a rare disorder, it should always be kept in the differential
diagnosis of a patient presenting with short stature. Patients with this disease have an excellent opportunity to
reach normal height if they present before the joining of epiphyses.
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Introduction
Pituitary stalk interruption syndrome (PSIS) is a rare congenital abnormality of the pituitary that is responsible
for anterior pituitary deficiency. It was first reported by
Fujisawa et al. [1]. It is associated with either isolated
growth hormone deficiency (GHD) or multiple anterior
pituitary hormone deficiencies (MPHD) - growth hormone
deficiency associated with abnormality of at least one of the
other anterior pituitary hormones, with normal function of
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posterior pituitary [2]. Although the exact prevalence of
PSIS is uncertain, a recently published report showed the
estimated incidence of 0.5 in every 1,000,000 births [3].
PSIS is characterized by a classic triad of interrupted
pituitary stalk, absent or ectopic posterior pituitary, and
anterior pituitary hypoplasia or aplasia [4]. Clinical presentation of PSIS depends on the age at the time of diagnosis. In neonates it presents as neonatal hypoglycemia,
prolonged neonatal (physiological) jaundice, cryptorchidism,
and micropenis. In older children and adults it is characterized by short stature [2,5]. Diagnosis of PSIS can be
suspected from clinical findings, but a magnetic resonance
imaging (MRI) scan can provide a definitive diagnosis.

© 2014 Ram et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
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MRI findings include hypoplasia or aplasia of the anterior pituitary, absence of the hyperintense posterior lobe
within the sella turcica and its presence at the level of the
median eminence or at the pituitary stalk level as a hyperintense nodule, and absent or thinned out pituitary stalk
[3,4,6,7].
Importance of early diagnosis of pituitary hormone
deficiencies is twofold. Firstly, if it remains untreated it
is associated with substantial mortality and morbidity.
Secondly, insufficient height at the onset of puberty leads to
short final height. Early diagnosis and treatment of GHD
is necessary to allow growth to reach a normal height
before puberty [8-10]. Most data on this syndrome is from
Western countries. Apart from China, no significant data
is available from Asian countries [3]. Here, we present the
case of a young man who presented to us with short stature and ultimately was found to have PSIS. To best of our
knowledge, this is the first ever reported case of PSIS from
Pakistan.

Case presentation
We report the case of a 17-year-old Pakistani young man
who presented with short stature and underdeveloped
secondary sexual characters. He had been operated on
for patent foramen ovale five years previously and the
procedure was uneventful. His birth history was found
to be significant due to breech presentation. He has experienced no delay in achieving developmental milestones,
his intelligence level was within the normal range, and his
school records reflected good performance. He had six
siblings, all of which were healthy, with normal height.
His mother and father had a height of 165cm and 154cm,
respectively. An examination showed that his pulse was
109/min, his blood pressure was 90/60mmHg, his height
was 142cm, his weight was 34.5kg, his body mass index
was 17.10kg/m2, and his calculated mid-parental height
(MPH) was 166.5cm, with an MPH range of 156.5 to
176.5cm. His Standard Deviation Score (SDS) was - 4.3.
He had no hair growth on his face, axilla, and pubis
(Tanner stage 1). Both of his testes were between 1 and
2mL in volume, and his stretch penile length was 4cm.
A systemic examination was unremarkable.
His lab investigations showed a fasting blood glucose
level of 85mg/dL, sodium at 141mmol/L, potassium at
3.8mmol/L, serum calcium at 9.4mg/dL, phosphorus at
6.2mg/dL (normal, 2.5 to 4.5mg/dL), albumin at 4.5gm/dL,
hemoglobin at 11.4g/dL, thyroid stimulating hormone
(TSH) at 8.58uIU/mL, free thyroxine at (FT4) 0.46ng/dL
(normal, 0.89 to 1.76ng/dL), an anti-thyroid peroxidase
antibody (anti-TPO) level of 17.8IU/mL (normal, less than
35IU/mL), and an anti-thyroglobulin antibodies level of
under 20IU/mL (normal, less than 40IU/mL), prolactin
at 21.1ng/mL (normal, 3.0 to 14.7ng/mL). A short synacthen
test revealed a morning baseline cortisol level of 0.30ug/dL
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(normal, 4.3 to 22.4ug/dL), and cortisol after 60 minutes of
250mcg cosyntropin injection was 3.5ug/dL. His insulin like
growth factor-1 (IGF-1) level was 31.56ng/mL (normal,
247.3 to 481.7ng/mL), his morning testosterone level was
under 2.5ng/dL (normal, 280 to 800ng/dL), his follicle
stimulating hormone level (FSH) was 0.41uIU/mL (normal,
0.0 to 10.0), and his luteinizing hormone level (LH) was
under 0.1uIU/mL (normal 1.2 to 7.8).
A biochemical picture favored an anterior pituitary hormones deficiency. Symptoms of diabetes insipidus such as
polyuria, polydipsia, nocturia, and nocturnal enuresis were
absent. His 24-hour urinary volume was 1800ml and his
serum osmolarity was 285mosm/kg.
His bone age was 10 years according to the Greulich
and Pyle method as was shown by his X-rays. A magnetic
resonance imaging (MRI) scan of his pituitary showed T1
hyperintense focus in the midline at the median eminence
with non-visualization of pituitary stalk. Posterior pituitary
was not seen in relation to the anterior pituitary in the pituitary fossa. Anterior pituitary was seen in pituitary fossa
at its normal location and was returning a normal signal.
This represented ectopic posterior pituitary with absent
pituitary stalk (Figure 1).

Discussion
PSIS is a rare congenital syndrome characterized by a classic triad of interrupted pituitary stalk, absent or ectopic
posterior pituitary, and anterior pituitary hypoplasia or

Figure 1 T1 weighted magnetic resonance image of the pituitary.
Pituitary stalk is absent (long arrow). Posterior pituitary is not seen in
relation to the anterior pituitary in the pituitary fossa and is seen as
hyperintense focus at the median eminence (short arrow). Anterior
pituitary is seen in pituitary fossa at its normal location and returning a
normal signal.
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aplasia. The pathogenesis of PSIS is still unknown. A
significant proportion of patients with congenital deficiency of pituitary hormones and PSIS are more likely
to have been delivered by breech or Cesarean section
and have suffered from neonatal hypoxemia than the
general population. Breech delivery leads to obvious
deformation of head which can result in injury to the
pituitary stalk. Similarly, hypoxemia due to anoxia after
birth may also lead to injury of the pituitary stalk and
pituitary. This has led to the belief by some investigators that PSIS is secondary to these events leading to
injury to this region during birth. However, the association of this syndrome with micropenis and cryptorchidism, as well as the occurrence of familial or syndromal
forms, suggests an antenatal origin of its pathogenesis.
Thus the abnormal birth data are a consequence and
not a cause of PSIS. Abnormal HESX1, LHX4, SOX3,
and PROKR2 genes have been reported in rare cases of
PSIS [3,4,9,11]. Between 20 and 50% of patients with PSIS
also have associated congenital malformations. These malformations include mainly the structures or organs along
the midline (for example, cleft lip, absence of diaphragm,
hypoplasia of optic nerve, bulging brain, or harelip) which
indicates that the gene defect corresponding to this disease may be related to the genes responsible for embryonic
development of the hypothalamus-pituitary area. Moreover,
those having isolated GHD have a higher risk of congenital
malformations as compared to those having multiple anterior pituitary deficiencies [3,4]. Our patient also had patent
foramen ovale. To the best of our knowledge, this association of PSIS has never been reported in literature.
Due to the limited number of reported cases of PSIS,
clinical manifestations of this disease are complex and diverse. Prolonged neonatal jaundice, hypoglycemia cryptorchidism, and micropenis are common presentations in
neonates. On the other hand, growth retardation is the
most common presentation in older children and adults.
Most patients lack sexual development [2,4,5]. Our patient
presented at adult age with short stature and lack of sexual
development. PSIS is a male predominant disease [3,5].
Age at the time of diagnosis has great variation in the literature. The age of our patient at diagnosis was 17 years,
which is much older than mean age of 3.6 years reported
by Gascoin-Lachambre et al. [10], 4.0 years by Pinto et al.
[4], and the 9.6 years reported by Reynaud et al. [5]. However, Guo et al. [3] reported a median age of 19.7 years in
his series which is closer to the age of our patient. The age
for diagnosis of symptomatic PSIS in various studies suggests an important delay in the diagnosis. Interestingly,
PSIS may progress from isolated GHD to multiple pituitary hormone deficiencies even during the second or third
decade of life. Similarly, our patient underwent a major
surgical intervention without developing adrenal crisis.
Close follow-up of such patients for monitoring of other
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hormonal deficiencies is essential if they initially present
with isolated GHD [2].
Our patient’s thyroid function tests favored secondary
hypothyroidism because of a very low FT4 level and slightly
increased TSH level, together with a negative anti-thyroid
antibodies level; Guo et al. [3] also reported such thyroid
function test results in a subgroup of PSIS patients [3]. He
is currently on hydrocortisone, thyroxine, growth hormone,
and low-dose sex steroids replacement for somatic and
sexual growth.
MRI findings of PSIS include hypoplasia or aplasia of
anterior pituitary, absence of the hyper intense posterior
lobe within the sella turcica and its presence at the level
of the median eminence or at the pituitary stalk level as
a hyper intense nodule, and absent or thinned out pituitary stalk [3,4,6,7]. However, there are variations in MRI
appearances of this syndrome. These variations include
the height of the anterior pituitary (from absence to normal),
the appearance of the posterior pituitary lobe (ectopic at the
base of the hypothalamus or along the pituitary stalk, absent,
or normal), and the form of the pituitary stalk (interrupted,
thin, absent, or normal). The abnormality can be limited
to an ectopic posterior pituitary [4].

Conclusions
We report the case of a young man who presented with
short stature and ultimately was found to have a rare congenital syndrome called PSIS. Despite the fact that PSIS is
a rare disorder it should always be kept in the differential
diagnosis of a patient presenting with short stature. Patients with this disease have an excellent opportunity to
reach their normal height if they present before the joining
of epiphyses.
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